Iscador Qu for chronic hepatitis C: an exploratory study.
Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany). Two patients showed 6-20 fold decreases in viral load and normalisation of liver inflammation. The treatment was well tolerated; no serious side effects were observed. The quality of life improved on average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.
Berg en Bosch Medical Centre, Bilthoven, the Netherlands. tusenius@worldonline.nl
K J
KJ
Tusenius
J M
JM
Spoek
C W
CW
Kramers
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use*; D010940:Plant Proteins; D011788:Quality of Life; D016896:Treatment Outcome; D019562:Viral Load
D000998:Antiviral Agents; D010936:Plant Extracts; D010940:Plant Proteins; C077177:viscum album peptide